Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kinetic Evaluation Instruments was a Netherlands-based life science tools company that designed and manufactured surface plasmon resonance (SPR) instruments, SPR-specific software, and bioanalytical sensors for research and disease-specific diagnostic applications. The company appears to have operated under the KEI brand and was described as a spin-out from Metrohm founded around 2012. Its offerings were focused on label-free molecular interaction analysis rather than therapeutics, with commercial instruments such as the Esprit line and related biosensor systems. Publicly available insolvency records indicate that Kinetic Evaluation Instruments B.V. entered bankruptcy proceedings in the Netherlands in March 2022, so it should not be considered an active operating biotech/pharma company today.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kinetic Evaluation Instruments.